Funding

Impress funding news – Barcelona-based Impress Raises Over €110 Million in its Latest Funding

Nov 13, 2024 | By Kailee Rainse

Impress funding news - Barcelona-based Impress Raises Over €110 Million in its Latest Funding

Impress, a leading orthodontic chain specializing in invisible aligners, has raised over €110 million in its latest funding round. The investment was led by Trinity Capital Inc., CareCapital, LBO France, and TA Ventures.

SUMMARY

  • Impress, a leading orthodontic chain specializing in invisible aligners, has raised over €110 million in its latest funding round.
  • Impress provides clear aligner treatments, a popular choice among both orthodontists and patients, to help people achieve healthy, well-aligned smiles with comfort and discretion.

Funding Utilisation

This funding will help Impress expand further, solidifying its position as Europe’s largest orthodontic chain and a top health tech company by revenue. The company plans to use the funds to continue its growth across Europe, open more clinics, and potentially enter new markets.

Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding

After acquiring DrSmile from the Straumann Group, the new capital will provide Impress with the resources to maintain its expansion and offer high-quality orthodontic care to more patients.

Dr. Khaled Kasem, Chief Orthodontic Officer and co-founder of Impress said: “With this financing, Impress has strengthened its position as Europe’s No. 1 orthodontic chain with primary focus on digitalisation. Our business model, deeply rooted in clinical excellence and bolstered by proprietary R&D, has proven resilient and highly scalable. This investment empowers us to build on our leadership in Europe and drive forward our vision of innovative, patient-centred orthodontic care.”

Impress Discription

It combines its own software with strong clinical supervision, which makes it stand out in the direct-to-consumer aligner market. By focusing on effective, doctor-supervised treatment plans, it has built a sustainable business model that works well for patients. This approach has helped the company succeed, especially when compared to U.S.-based aligner companies that have faced more challenges.

Dr. Kasem said, “Impress’s model is built for long-term success, focusing on effective, medically supervised treatments for all orthodontic cases. With this latest funding, we’re prepared to reach even more patients across Europe and deliver the confidence of a healthy, beautiful smile,”.

By acquiring DrSmile, Impress has expanded into important European markets like Germany, France, the Netherlands, and Sweden. This move helps Impress work toward becoming one of Europe’s largest health tech companies by revenue.

With the new funding, it plans to open over 20 flagship clinics by 2025, allowing it to offer high-quality orthodontic care across Europe.

About Impress

Impress provides clear aligner treatments, a popular choice among both orthodontists and patients, to help people achieve healthy, well-aligned smiles with comfort and discretion. Their goal is to help individuals feel confident and proud of their smile.

Recommended Stories for You